| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Asymmetric dimethylarginineAngiogenesisNitric oxide NO| 1 | 2003 | The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. | 
| + | - | nl | Cardiovasc Res 59(4):824-33 (2003) |
| 2 | 1999 | Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. |
| + | - | nl | Cardiovasc Res 43(3):542-8 (1999) |
| 3 | 2004 | Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure? |
| + | - | nl | J Nutr 134(10 Suppl):2848S-2852S; discussion 2853S (2004) |
| 4 | 2004 | Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. |
| + | - | nl | J Nutr 134(10 Suppl):2842S-2847S; discussion 2853S (2004) |
| 5 | 2008 | Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review. |
| + | - | nl | Am J Nephrol 28(2):224-37 (2008) |
| 6 | 2005 | L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. |
| + | - | nl | Altern Med Rev 10(1):14-23 (2005) |
| 7 | 2011 | Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury? |
| + | - | nl | World J Gastroenterol 17(17):2178-80 (2011) |
| 8 | 2010 | A miR-thless perspective: how asymmetric dimethylarginine impairs the functions of angiogenic progenitor cells. |
| + | - | nl | Circ Res 107(1):12-4 (2010) Brandes RP |
| 9 | 2003 | When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease. |
| + | - | nl | Eur Heart J 24(21):1901-2 (2003) |
| 10 | 2007 | Should we measure asymmetric dimethylarginine in patients with coronary artery disease? |
| + | - | nl | Clin Chem 53(2):161-3 (2007) Kielstein JT |
| 11 | 2006 | Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. |
| + | - | nl | Pharmacol Rep 58(2):159-78 (2006) |
| 12 | 2006 | Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials. |
| + | - | nl | Pharmacol Rep 58 Suppl(-):16-20 (2006) |
